The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126073761 12607376 1 I 20160704 20160722 20160729 20160729 EXP FR-SA-2016SA136207 AVENTIS 65.00 YR E M Y 0.00000 20160729 OT FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126073761 12607376 1 SS DIAMOX SEQUELS ACETAZOLAMIDE 1 Oral Y U 0 2.5 MG QD
126073761 12607376 2 SS FUROSEMIDE. FUROSEMIDE 1 Oral Y U 0 20 MG QD
126073761 12607376 3 PS LOVENOX ENOXAPARIN SODIUM 1 Subcutaneous U 20164
126073761 12607376 4 SS BRILIQUE TICAGRELOR 1 Oral U 0 2 DF FILM-COATED TABLET QD
126073761 12607376 5 SS OMNIPAQUE IOHEXOL 1 Intravenous (not otherwise specified) U 0 185 ML 1X
126073761 12607376 6 SS AGRASTAT TIROFIBAN HYDROCHLORIDE 1 Intravenous (not otherwise specified) U 0
126073761 12607376 7 SS BISOCE BISOPROLOL 1 Oral FORM-FILM COATED DIVISIBLE TABLET; 2.5MG Y U 0 1 DF QD
126073761 12607376 8 C RAMIPRIL. RAMIPRIL 1 Oral 0 20 MG QD
126073761 12607376 9 C TAHOR ATORVASTATIN CALCIUM 1 Oral 80MG 0 1 DF FILM-COATED TABLET QD
126073761 12607376 10 C KARDEGIC ASPIRIN LYSINE 1 Oral POWDER FOR ORAL SOLUTION IN DOSE SACHET 0 1 DF QD
126073761 12607376 11 C ASPEGIC ASPIRIN DL-LYSINE 1 Oral POWDER FOR ORAL SOLUTION IN DOSE SACHET 0 1X
126073761 12607376 12 C PLAVIX CLOPIDOGREL BISULFATE 1 Oral 0 FILM-COATED TABLET
126073761 12607376 13 C MORPHINE MORPHINE 1 0
126073761 12607376 14 C PRIMPERAN METOCLOPRAMIDE HYDROCHLORIDE 1 0
126073761 12607376 15 C PARACETAMOL ACETAMINOPHEN 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126073761 12607376 1 Myocardial infarction
126073761 12607376 2 Myocardial infarction
126073761 12607376 3 Chest pain
126073761 12607376 4 Myocardial infarction
126073761 12607376 5 Scan with contrast
126073761 12607376 6 Coronary angioplasty
126073761 12607376 8 Myocardial infarction
126073761 12607376 9 Myocardial infarction
126073761 12607376 10 Myocardial infarction
126073761 12607376 11 Chest pain
126073761 12607376 12 Myocardial infarction

Outcome of event

Event ID CASEID OUTC COD
126073761 12607376 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126073761 12607376 Chills
126073761 12607376 Malaise
126073761 12607376 Rash maculo-papular

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126073761 12607376 1 20160701 20160705 0
126073761 12607376 2 20160701 20160706 0
126073761 12607376 3 20160630 20160630 0
126073761 12607376 4 20160701 0
126073761 12607376 5 20160701 20160701 0
126073761 12607376 6 20160702 20160702 0
126073761 12607376 7 20160701 20160705 0
126073761 12607376 8 20160701 20160706 0
126073761 12607376 9 20160701 0
126073761 12607376 10 20160701 0
126073761 12607376 11 20160630 20160630 0
126073761 12607376 12 20160630 20160630 0